Trade Pharming Group N.V. - PHAR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.032 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.022099% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000123% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Netherlands | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.868 |
| Open | 0.883 |
| 1-Year Change | -11.43% |
| Day's Range | 0.883 - 0.898 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | 0.868 | -0.030 | -3.34% | 0.898 | 0.903 | 0.868 |
| Apr 24, 2024 | 0.899 | -0.014 | -1.53% | 0.913 | 0.913 | 0.888 |
| Apr 23, 2024 | 0.905 | 0.002 | 0.22% | 0.903 | 0.920 | 0.882 |
| Apr 22, 2024 | 0.895 | 0.017 | 1.94% | 0.878 | 0.909 | 0.877 |
| Apr 19, 2024 | 0.878 | 0.007 | 0.80% | 0.871 | 0.884 | 0.863 |
| Apr 18, 2024 | 0.873 | -0.079 | -8.30% | 0.952 | 0.952 | 0.848 |
| Apr 17, 2024 | 0.948 | -0.005 | -0.52% | 0.953 | 0.963 | 0.945 |
| Apr 16, 2024 | 0.958 | -0.008 | -0.83% | 0.966 | 0.975 | 0.948 |
| Apr 15, 2024 | 0.982 | -0.016 | -1.60% | 0.998 | 1.008 | 0.978 |
| Apr 12, 2024 | 1.007 | 0.010 | 1.00% | 0.997 | 1.023 | 0.997 |
| Apr 11, 2024 | 0.994 | -0.001 | -0.10% | 0.995 | 1.004 | 0.985 |
| Apr 10, 2024 | 0.992 | 0.004 | 0.40% | 0.988 | 0.997 | 0.980 |
| Apr 9, 2024 | 0.985 | 0.009 | 0.92% | 0.976 | 0.991 | 0.959 |
| Apr 8, 2024 | 0.985 | -0.005 | -0.51% | 0.990 | 0.997 | 0.980 |
| Apr 5, 2024 | 0.994 | -0.002 | -0.20% | 0.996 | 1.003 | 0.990 |
| Apr 4, 2024 | 1.008 | 0.012 | 1.20% | 0.996 | 1.014 | 0.996 |
| Apr 3, 2024 | 1.007 | 0.007 | 0.70% | 1.000 | 1.011 | 0.989 |
| Apr 2, 2024 | 0.998 | -0.015 | -1.48% | 1.013 | 1.013 | 0.997 |
| Mar 28, 2024 | 1.007 | 0.000 | 0.00% | 1.007 | 1.022 | 0.985 |
| Mar 27, 2024 | 1.003 | -0.012 | -1.18% | 1.015 | 1.029 | 0.991 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Pharming Group Company profile
About Pharming Group N.V.
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Pharming Group N.V. revenues decreased 10% to EUR167.7M. Net income decreased 59% to EUR13.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research and development increase of 76% to EUR59.3M (expense), General and administrative increase of 48% to EUR31.2M (expense).
Equity composition
4/2010, Nominal value changed from EUR 0.5. 07/2012, Nominal value changed from EUR0.04. 3/2013, 1-for-10 reverse stock split (Factor: 0.1 ). 3/2013, Nominal value changed from EUR0.1 to EUR0.01. 11/2016, Rights Issue, 1 new share for every 7 shares held @ 0.205EUR, (Factor: 1.00751).
| Industry: | Pharmaceuticals (NEC) |
Darwinweg 24
LEIDEN
ZUID-HOLLAND 2333 CR
NL
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com